Comparative study between non-blinded, randomized, parallel group regarding the preventive effect of the coarse-hydrochloride landiolol for atrial fibrillation after major thoracic vascular surgery
Not Applicable
- Conditions
- thoracic aortic aneurysm, thoracic aortic dissection
- Registration Number
- JPRN-UMIN000017551
- Lead Sponsor
- Hiroshima University Institute of Biomedical and Health Sciences Applied Life Sciences Surgery
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Not provided
Exclusion Criteria
Corresponding to patient contraindications hydrochloride landiolol Patients with acute myocardial infarction within 3 days. Patients with supraventricular arrhythmia that might need treatment. Patients with severe heart failure (NYHA III degrees or more just before surgery, EF less than 35%). Patients with atrial fibrillation cause of electrolyte abnormalities, WPW syndrome and hyperthyroidism. Diastolic blood pressure / systolic patients less than 90/60 mmHg. Patients with severe asthma. Patients who take an oral antiarrhythmic drugs or beta blocker. Patients who were found to be inappropriate physician to carry out the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The proportion of patients with atrial fibrillation coarse-until 7 days after surgery occurred.
- Secondary Outcome Measures
Name Time Method